Literature DB >> 30600484

MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes.

Xi Yang1, Jiang Bian1, Yan Gong2, William R Hogan1, Yonghui Wu3.   

Abstract

INTRODUCTION: Early detection of adverse drug events (ADEs) from electronic health records is an important, challenging task to support pharmacovigilance and drug safety surveillance. A well-known challenge to use clinical text for detection of ADEs is that much of the detailed information is documented in a narrative manner. Clinical natural language processing (NLP) is the key technology to extract information from unstructured clinical text.
OBJECTIVE: We present a machine learning-based clinical NLP system-MADEx-for detecting medications, ADEs, and their relations from clinical notes.
METHODS: We developed a recurrent neural network (RNN) model using a long short-term memory (LSTM) strategy for clinical name entity recognition (NER) and compared it with baseline conditional random fields (CRFs). We also developed a modified training strategy for the RNN, which outperformed the widely used early stop strategy. For relation extraction, we compared support vector machines (SVMs) and random forests on single-sentence relations and cross-sentence relations. In addition, we developed an integrated pipeline to extract entities and relations together by combining RNNs and SVMs.
RESULTS: MADEx achieved the top-three best performances (F1 score of 0.8233) for clinical NER in the 2018 Medication and Adverse Drug Events (MADE1.0) challenge. The post-challenge evaluation showed that the relation extraction module and integrated pipeline (identify entity and relation together) of MADEx are comparable with the best systems developed in this challenge.
CONCLUSION: This study demonstrated the efficiency of deep learning methods for automatic extraction of medications, ADEs, and their relations from clinical text to support pharmacovigilance and drug safety surveillance.

Entities:  

Mesh:

Year:  2019        PMID: 30600484      PMCID: PMC6402874          DOI: 10.1007/s40264-018-0761-0

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  12 in total

1.  Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.

Authors:  Feifan Liu; Abhyuday Jagannatha; Hong Yu
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

2.  Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.

Authors:  Stella Stergiopoulos; Mortiz Fehrle; Patrick Caubel; Louise Tan; Louise Jebson
Journal:  Pharmaceut Med       Date:  2019-12

3.  The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.

Authors:  Maribel Salas; Jan Petracek; Priyanka Yalamanchili; Omar Aimer; Dinesh Kasthuril; Sameer Dhingra; Toluwalope Junaid; Tina Bostic
Journal:  Pharmaceut Med       Date:  2022-07-29

Review 4.  Intelligent Telehealth in Pharmacovigilance: A Future Perspective.

Authors:  Heba Edrees; Wenyu Song; Ania Syrowatka; Aurélien Simona; Mary G Amato; David W Bates
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

Review 5.  Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0).

Authors:  Abhyuday Jagannatha; Feifan Liu; Weisong Liu; Hong Yu
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

Review 6.  Artificial Intelligence for Drug Toxicity and Safety.

Authors:  Anna O Basile; Alexandre Yahi; Nicholas P Tatonetti
Journal:  Trends Pharmacol Sci       Date:  2019-08-02       Impact factor: 14.819

7.  Identifying relations of medications with adverse drug events using recurrent convolutional neural networks and gradient boosting.

Authors:  Xi Yang; Jiang Bian; Ruogu Fang; Ragnhildur I Bjarnadottir; William R Hogan; Yonghui Wu
Journal:  J Am Med Inform Assoc       Date:  2020-01-01       Impact factor: 4.497

Review 8.  Applications of artificial intelligence in drug development using real-world data.

Authors:  Zhaoyi Chen; Xiong Liu; William Hogan; Elizabeth Shenkman; Jiang Bian
Journal:  Drug Discov Today       Date:  2020-12-24       Impact factor: 7.851

9.  Determining the prevalence of cannabis, tobacco, and vaping device mentions in online communities using natural language processing.

Authors:  Mengke Hu; Ryzen Benson; Annie T Chen; Shu-Hong Zhu; Mike Conway
Journal:  Drug Alcohol Depend       Date:  2021-09-06       Impact factor: 4.492

10.  Artificial intelligence-based conversational agent to support medication prescribing.

Authors:  Anita M Preininger; Brett South; Jeff Heiland; Adam Buchold; Mya Baca; Suwei Wang; Rex Nipper; Nawshin Kutub; Bryan Bohanan; Gretchen Purcell Jackson
Journal:  JAMIA Open       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.